It was demonstrated that AKR1B10 was identified as a direct target of p53 family and the overexpression of AKR1B10 enhanced p53-induced apoptosis and inhibited tumor proliferation in CRC cell-line and xenograft model46. Here, AKR1B10 is linked to neoplasm.